A Deletion Mutation of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Locus: DeltaI507
- 1 January 1991
- book chapter
- Published by Springer Nature
- Vol. 290, 393-398
- https://doi.org/10.1007/978-1-4684-5934-0_48
Abstract
During the development of an amplification refractory mutation system (ARMS)1 assay for the detection of the DeltaF508 mutation2,3,4 and corresponding normal locus in cystic fibrosis we discovered a family in which a further variant of the sequence exists. PCR amplification and direct sequencing of a region of exon 10 of the CFTR locus indicated the deletion of the three base pairs encoding isoleucine506 or isoleucine507, or possibly the presence of a single base substitution in conjunction with the DeltaF508 mutation. The resulting protein has a deletion of an isoleucine residue at position 507 as opposed to the previously described deletion of phenylalanine at position 508. We conclude that the loss of an isoleucine residue at position 507 (DeltaI507) is another defective variant of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene product.Keywords
This publication has 6 references indexed in Scilit:
- Identification of the Cystic Fibrosis Gene: Chromosome Walking and JumpingScience, 1989
- Identification of the Cystic Fibrosis Gene: Genetic AnalysisScience, 1989
- Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNAScience, 1989
- Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)Nucleic Acids Research, 1989
- Diagnosis of α1antitrypsin deficiency by enzymatic amplification of human genomic DNA and direct sequencing of polymerase chain reaction productsNucleic Acids Research, 1988
- Patterns of polymorphism and linkage disequilibrium for cystic fibrosisGenomics, 1987